share_log

Hims & Hers Health | 8-K: Current report

Hims & Hers Health | 8-K: Current report

Hims & Hers Health | 8-K：重大事件
美股SEC公告 ·  2024/09/09 11:16

Moomoo AI 已提取核心訊息

Hims & Hers Health has completed the acquisition of Seaview Enterprises LLC (d/b/a MedisourceRx) on September 5, 2024, acquiring 100% of its membership interests from Nivagen Pharmaceuticals. The transaction was executed through a purchase agreement dated July 5, 2024.As part of the acquisition terms, Hims & Hers issued 976,341 shares of Class A common stock to Nivagen Pharmaceuticals. The company has filed a prospectus supplement on September 9, 2024, to register these resale shares, which was done in accordance with the purchase agreement and under an exemption from Securities Act registration requirements.
Hims & Hers Health has completed the acquisition of Seaview Enterprises LLC (d/b/a MedisourceRx) on September 5, 2024, acquiring 100% of its membership interests from Nivagen Pharmaceuticals. The transaction was executed through a purchase agreement dated July 5, 2024.As part of the acquisition terms, Hims & Hers issued 976,341 shares of Class A common stock to Nivagen Pharmaceuticals. The company has filed a prospectus supplement on September 9, 2024, to register these resale shares, which was done in accordance with the purchase agreement and under an exemption from Securities Act registration requirements.
Hims & HERS Health於2024年9月5日完成了對Seaview Enterprises LLC（經營名稱爲MedisourceRx）的收購，收購了Nivagen Pharmaceuticals100%的會員權益。該交易是通過2024年7月5日簽署的購買協議執行的。作爲收購條款的一部分，Hims & HERS向Nivagen Pharmaceuticals發行了976,341股A類普通股。公司已於2024年9月9日提交了一份招股說明書補充，註冊這些可轉售的股票，這是根據購買協議並在證券法註冊要求的豁免下進行的。
Hims & HERS Health於2024年9月5日完成了對Seaview Enterprises LLC（經營名稱爲MedisourceRx）的收購，收購了Nivagen Pharmaceuticals100%的會員權益。該交易是通過2024年7月5日簽署的購買協議執行的。作爲收購條款的一部分，Hims & HERS向Nivagen Pharmaceuticals發行了976,341股A類普通股。公司已於2024年9月9日提交了一份招股說明書補充，註冊這些可轉售的股票，這是根據購買協議並在證券法註冊要求的豁免下進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    樸荷生物科技
    PHH
    -- 5.700
    Grove Collaborative
    GROV
    -- 1.4500
    大樹雲
    DSY
    -- 3.073
    Hims & Hers Health
    HIMS
    -- 30.890
    Waldencast
    WALD
    -- 3.310
    解鎖完整榜單
    熱門討論
    特朗普2.0時代開啓，全球股市新風口在哪裏？
    ▪️加密貨幣政策能否利好crypto? ▪️關稅政策能否利好中概等海外資產？ ▪️在特朗普政策下，有哪些投資機會值得關注？ 展开
    離川普上臺只有7天了～
    熱門中概股
    追蹤最熱門的中概股實時資訊。